Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera (dimethyl fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
|Effective start/end date||9/1/13 → 8/31/16|
- BIOGEN INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.